Chapter 1 Tissue preparation and banking

Progress in Brain Research

Volumn 158, Issue , 2006, Pages 3-14

  Webster, Maree J ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

AUTOPSY; BRAIN; CADAVER; HEALTH CARE FACILITY; HISTOLOGY; HUMAN; PATHOLOGY; REVIEW;

AUTOPSY; BRAIN; HISTOLOGICAL TECHNIQUES; HUMANS; POSTMORTEM CHANGES; RNA; TISSUE BANKS;

EID: 33749234410     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(06)58001-X     Document Type: Review

References (71)

1. Altar C.A., Jurata L.W., Charles V., Lemire A., Liu P., Bukham Y., Young T.A., Bullard J., Yokoe H., Webster M.J., Knable M.B., and Brockman J.A. Deficient expression of proteasome, ubiquitin, and mitochondrial genes in hippocampal neurons of multiple schizophrenia patient groups. Biol. Psychiatry 58 (2005) 85-96
2. Barton A.J.L., Pearson R.C.A., Najlerahin A., and Harrison P.J. Pre- and postmortem influences on brain RNA. J. Neurochem. 61 (1993) 1-11
3. Bauer M., Gramlich I., Polzin, and Patzelt D. Quantification of mRNA degradation as possible indicator of postmortem interval - a pilot study. Legal Med. 5 (2003) 220-227
4. Bunney W.E., Bunney B.G., Vawter M.P., Tomita H., Li J., Evans S.J., Choudary P.V., myers R.M., Jones E.G., Watson S.J., and Akil H. Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am. J. Psychiatry 160 (2003) 657-666
5. Butterfield D.A. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res. 1000 (2004) 1-7
6. Butterfield D.A., and Castegna A. Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders. Amino Acids 25 (2003) 419-425
7. Burke W.J., O'Malley K.L., Chung H.D., Harmon S.K., Miller J.P., and Berg L. Effect of pre- and postmortem variables on specific mRNA levels in human brain. Mol. Brain Res. 11 (1991) 37-41
8. Castensson A., Emilsson L., Preece P., and Jazin E. High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res. 10 (2000) 1219-1229
9. Eastwood S.L., McDonald B., Burnet P.W.J., Beckwith J.P., Kerwin R.W., and Harrison P.J. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Mol. Brain Res. 29 (1995) 211-223
10. Edgar P.F., Douglas J.E., Cooper G.J.S., Dean B., Kydd R., and Faull R.L.M. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol. Psychiatry 5 (2000) 85-90
11. Edgar P.F., Douglas J.E., Knight C., Cooper G.J.S., Faull R.L.M., and Kydd R. proteome map of the human hippocampus. Hippocampus 9 (1999) 644-650
12. Edgar P.F., Schonberger S.J., Dean B., Faull R.L.M., Kydd R., and Cooper G.J.S. A comparative proteome analysis of hippocampus from schizophrenic and Alzheimer's disease individuals. Mol. Psychiatry 4 (1999) 173-178
13. Erraji-Benchekroun L., Underwood M.D., Arango V., Galfalvy H., Pavlidis P., Smyrniotopoulos P., Mann J.J., and Sibille E. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol. Psychiatry 57 (2005) 549-558
14. Fernandez-Guasti A., Kruijver F.P., Fodor M., and Swaab D.F. Sex differences in the distribution of androgen receptors in the human hypothalamus. J. Comp. Neurol. 425 (2000) 422-435
15. Fountoulakis M., Hardmeier R., Hoger H., and Lubec G. Postmortem changes in the level of brain proteins. Exp. Neurol. 167 (2001) 86-94
16. Greber S., Lubec G., Cairns N., and Fountoulakis M. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease. Electrophoresis 20 (1999) 928-934
17. Green R., Clark A., Hickey W., Hutsler J., and Gazzaniga M. Braincutting for psychiatrists: the time is ripe. J. Neuropsychiatry Clin. Neurosci. 11 (1999) 301-306
18. Hardy J.A., Wester B., Winlad B., Gezelius C., Bring G., and Eriksson A. The patients dying after long terminal phase have acidotic brains: implications for biochemical measurements on autopsy tissue. J. Neural Transm. 61 (1985) 253-264
19. Halpern M.E., Gunturkun O., Hopkins W.D., and Rogers L.J. Lateraliization of the vertebrate brain: taking the side of model systems. J. Neurosci. 25 (2005) 10351-10357
20. Hamacher M., Klose J., Rossier J., Marcus K., and Meyer H.E. Does understanding the brain need proteomics and does understanding proteomics need brain?" - Second HUPO HBPP workshop hosted in Paris. Proteomics 4 (2004) 1932-1934
21. 31P-MRS in bipolar disorder. Psychiatry Clin. Neurosci. 58 (2004) 82-88
22. Harrison P.J., Procter A.W., Barton A.J.L., Lowes S.L., Najlerahim A., Bertolucci P.H., Bowen D.M., and Pearson R.C.A. Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Mol. Brain Res. 9 (1991) 161-164
23. Harrison P.J., Heath P.R., Eastwood S.L., Burnet P.W.J., McDonald B., and Pearson R.C.A. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200 (1995) 151-154
24. Healy D.J., Sima A.A.F., Tapp A., Watson S.J., and Meador-Woodruff J.H. J. Psychiat. Res. 30 (1996) 45-49
25. Hynd M.R., Lewohl J.M., Scott H.L., and Dodd P.R. Biochemical and molecular studies using human autopsy brain tissue. J. Neurochem. 85 (2003) 543-562
26. Inoue H., Kimura A., and Tuji T. Degradation profile of mRNA in a dead rat body: basic semi-quantification study. Forensic Sci. Internat. 130 (2002) 127-132
27. Johnson S.A., Morgan D.G., and Finch C.E. Extensive postmortem stability of RNA from rat and human brain. J. Neurosci. Res. 16 (1986) 267-280
28. Johnston N.L., Cervenak J., Torrey E.F., and Yolken R. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. J. Neurosci. Methods 77 (1997) 83-92
29. Johnston-Wilson N.L., Sims C.D., Hofmann J.-P., Anderson L., Shore A.D., Torrey E.F., and Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol. Psychiatry 5 (2000) 142-149
30. Karry R., Klein E., and Ben Shachar D. Mitochondrial complex 1 subunits expression is altered in schizophrenia: a postmortem study. Biol. Psychiatry 55 (2004) 676-684
31. 31P-magnetic resonance spectroscopic findings to their molecular mechanisms. International Rev. Neurobiol. 63 (2005) 21-40
32. Katsel, P.L., Davis, K.L. and Haroutunian, V. (2005) Large scale microarray studies of gene expression in multiple regions of the brain in schizophrenia. Int. Rev. Neurobio., 63: 41-82.
33. Kim S.I., Voshol H., van Oostrum J., Hastings T.G., Cascio M., and Glucksman M.J. Neuroproteomics: expression profiling of the brain's proteomes in health and disease. Neurochem. Res. 29 (2004) 1317-1331
34. Kingsbury A.E., Foster O.J.F., Nisbet A.P., Cairns N., Bray L., Eve D.J., Lees A.J., and Marsden C.D. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol. Brain Res. 28 (1995) 311-318
35. Kittel D.A., Hyde T.M., Herman M.M., and Kleinman J.E. The collection of tissue at autopsy: practical and ethical issues. In: Dean B., Kleinman J.E., and Hyde T.M. (Eds). Using CNS Tissue in Psychiatric Research: A Practical Guide (1999), Harwood Academic Publishers, Amsterdam, The Netherlands 1-18
36. Kleinman J.E., Hyde T.M., and Herman M.M. Methodological issues in the neuropathology of mental illness. In: Bloom F.E., and Kupfer D.J. (Eds). Psycopharmacology: The Fourth Generation of Progress (1995), Raven Press, Ltd., New York 859-864
37. Knable M.B., Barci B.M., Bartko J.J., Webster M.J., and Torrey E.F. Molecular predictors of major psychiatric illness: classification and regression tree (CART) analysis of post-mortem prefrontal markers. Mol. Psychiatry 7 (2002) 392-404
38. Knable M.B., Barci B.M., Bartko J.J., Webster M.J., and Torrey E.F. Abnormalities of the cingulate gyrus in bipolar disorder and other severe psychiatric illness: post-mortem findings from the Stanley Foundation Neuropathology Consortium and literature review. Clin. Neurosci. Res. 2 (2002) 171-181
39. Knable M.B., Barci B.M., Webster M.J., and Torrey E.F. Summary of prefrontal molecular abnormalities in the Stanley Foundation Neuropathology Consortium. In: Agam G., Everall I., and Belmaker R.H. (Eds). The Post-Mortem Brain in Psychiatric Research (2001), Kluwer, Boston 105-137
40. Knable M.B., Barci B.M., Webster M.J., and Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: Post-mortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 9 (2004) 609-620
41. Knable M.B., Torrey E.F., Webster M.J., and Bartko J. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res. Bull. 55 (2001) 651-660
42. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., and Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder 61 (2004) 300-308
43. Kruijver F.P., Fernandez-Guasti A., Fodor M., Kraan E.M., and Swaab D.F. Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J. Clin. Endocrinol. Metab. 86 (2001) 818-827
44. Law A., Shannon-Weickert C., Webster M.J., Herman M.M., Kleinman J.E., and Harrison P.J. Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation. Eur. J. Neurosci. 18 (2003) 1197-1205
45. Leonard S., Logel J., Luthman D., Casanova M., Kirch D., and Freedman R. Biological stability of mRNA isolated from human postmortem brain collections. Biol. Psychiatry 33 (1993) 456-466
46. Lewis D.A. The human brain revisited: Opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharm 26 (2002) 143-154
47. Lewohl J.M., van Dyk D.D., Craft G.E., Innes D.J., Mayfield R.D., Cobon G., Harris R.A., and Dodd P.R. The application of proteomics to the human alcoholic brain. Ann. N.Y. Acad. Sci. 1025 (2004) 14-26
48. Li J.Z., Vawter M.P., Walsh D.M., Tomita H., Evans S.J., Choudary P.V., Lopez J.F., Avelar A., Shokoohi V., Chung T., Mesarwi O., Jones E.G., Watson S.J., Akil H., Bunney W.E., and Meyers R.M. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet. 13 (2004) 609-616
49. Lubec G., Krapfenbauer K., and Fountoulakis M. Proteomics in brain research: potentials and limitations. Prog. Neurobiol. 69 (2003) 193-211
50. Miller C.L., Diglisic S., Leister F., Webster M.J., and Yolken R.H. Evaluating RNA status for RT/PCR in extracts of postmortem human brain tissue. BioTechniques 36 (2004) 628-633
51. Mirnics K., Middleton F.A., Lewis D.A., and Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24 (2001) 479-486
52. Newcombe J., Eriksson B., Ottervald J., Yang Y., and Franzen B. Extraction and proteomic analysis of protein from normal and multiple sclerosis postmortem brain. J. Chromatog. B 815 (2005) 191-201
53. Nichols N.R., Day J.R., Laping N.J., Johnson S.A., and Finch C.E. GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 14 (1993) 421-429
54. Perret C.W., Marchbanks R.M., and Whatley S.A. Characterisation of messenger RNA extracted post-mortem from the brains of schizophrenic, depressed and control subjects. J. Neurol. Neurosurg. Psych 51 (1988) 325-331
55. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T.-J., Griffin J.L., Wayland M., Freeman T., Durbridge F., Lilley K.S., Karp N.A., Hester S., Trachev D., Mimmack M.M., Yolken R.H., Webster M.J., Torrey E.F., and Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9 (2004) 684-697
56. Preece P., and Cairns N.J. Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Mol. Brain Res. 118 (2003) 60-71
57. Romanczyk T.B., Shannon Weickert C., Webster M.J., Akil M., Herman M.M., and Kleinman J.E. Full-length trkB mRNA increases during young adulthood and decreases during aging in the human prefrontal cortex. Eur. J. Neurosci. 15 (2002) 269-280
58. Ryan, M.M., Lockstone, H.E., Wayland, M.T., Huffacker, S.J., Webster, M.J. and Bahn, S. (2006) Gene expression analysis of bipolar disorder reveals down-regulation of the ubiquitin cycle and alterations in synaptic genes. Molecular Psychiatry (In Press).
59. Shankar S.K., and Mahadevan A. Relevance of human brain banking in neuroscience - a national facility. Ann. Ind. Acad. Neurol. 2 (1999) 59-70
60. Schonberger S.J., Edgar P.F., Kydd R., Faull R.L.M., and Cooper G.J.S. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 1 (2001) 1519-1528
61. Swatton J.E., Prabakaran S., Karp N.A., Lilley K.S., and Bahn S. Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Mol. Psychiatry 9 (2004) 1-16
62. Tomita H., Vawter M.P., walsh D.M., Evans S.J., Choudary P.V., Li J., Overman K.M., Atz m.E., Myers R.M., jones E.G., Watson S.J., Akil H., and Bunney W.E. Effects of agonal and postmortem factors on gene expression profile: quality control in microarray analysis of postmortem human brain. Biol. Psychiatry 55 (2004) 346-352
63. Torrey E.F., Webster M., Knable M., Johnston N., and Yolken R.H. The Stanley Foundation brain collection and neuropathology consortium. Schizophr. Res. 44 (2000) 151-155
64. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meader-Woodruff J.H., and Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 57 (2005) 252-260
65. Trotter S.A., Brill L.B., and Bennett J.P. Stability of gene expression in postmortem brain revealed by cDNA gene array analysis. Brain Res. 942 (2002) 120-123
66. Vonsattel J.P.G., Aizawa H., Ge P., DiFiglia M., McKee A.C., MacDonald M., Gusella J.F., Landwehrmeyer G.B., Bird E.D., Richardseon E.P., and Hedley-Whyte E.T. An improved approach to prepare human brains for research. J. Neuropath. Exp. Neurol. 54 (1995) 42-56
67. Voshol H., Glucksman M.J., and Oostrum J. Proteomics in the discovery of new therapeutic targets for psychiatric disease. Curr. Mol. Med. 3 (2003) 447-458
68. Webster M.J., Knable M.B., O'Grady J., Orthmann J., and Shannon Weickert C. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry 7 (2002) 985-994
69. Webster M.J., Shannon Weickert C., Herman M.M., and Kleinman J.E. BDNF mRNA expression during postnatal development of the human prefrontal cortex. Dev. Brain Res. 139 (2002) 139-150
70. Yasojima K., McGeer E.G., and McGeer P.L. High stability of mRNAs postmortem and protocols for their assessment by RT-PCR. Brain Res. Protoc. 8 (2001) 212-218
71. Yates C., Butterworth J., Tennant M.C., and Gordon A. Enzyme activities in relation to pH and lactate in post-mortem brain in Alzheimer-type and other dementias. J. Neurochem. 55 (1990) 1624-1630